Fast-track status is intended to speed the development and review of treatments for serious conditions with unmet medical needs. It will allow Spinogenix to have more frequent interactions with the ...
The FDA has granted Fast Track designation to tazbentetol for the treatment of amyotrophic lateral sclerosis (ALS).
PIONEER-ALS, a clinical trial evaluating VTx-002 as a treatment for ALS, has been given a green light to launch study sites in three European nations. The therapy targets toxic TDP-43 protein clumps, ...
Stem cells are a potential treatment for ALS currently being studied in clinical trials. This treatment is not FDA-approved at this time, and the results of these trials will determine whether it ever ...
Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering novel therapeutics that have the potential to restore synapses to improve the lives of patients worldwide, today announced that ...
Clene Inc. CLNN shares are up 6.68% on Monday as the company is filing for accelerated approval of its ALS treatment ...
Just 3 disease-modifying treatments—edaravone, riluzole, and sodium phenylbutyrate and taurursodiol (PB/TURSO)—are currently FDA approved to slow progression of amyotrophic lateral sclerosis (ALS). A ...
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal ...
My son Matt was diagnosed with ALS in April 2014, just a few months before the ice bucket challenge took off on social media. Many people remember this as a rare moment when our country was united in ...
Some evidence reports natural medications, such as Wugongtang and Dihuangyinzi, may help slow the progression of ALS or Lou Gehrig’s disease. However, they cannot cure it. Amyotrophic lateral ...
ALS causes muscle weakness and difficulty with mobility, flexibility, and balance. Physical therapy may help you maintain these skills and perform tasks independently for as long as possible. Share on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results